首页> 外文期刊>Journal of cataract and refractive surgery >Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation. Comparison of clinical outcomes.
【24h】

Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation. Comparison of clinical outcomes.

机译:联合手术和序贯手术,包括超声乳化,平面玻璃体切除术和人工晶状体植入术。临床结果比较。

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the effectiveness and safety of combined phacoemulsification, pars plana vitrectomy (PPV), and intraocular lens (IOL) implantation in diabetic and nondiabetic patients and compare the clinical results with those of sequential surgery.Seoul National University College of Medicine, Seoul, South Korea.The results of combined phacoemulsification, PPV, and IOL implantation in 52 patients (52 eyes) were retrospectively analyzed. The main outcome measures were preoperative and postoperative best corrected visual acuity (BCVA), postoperative BCVA of 20/40 or better, and intraoperative and postoperative complications. Combined surgery and sequential surgery were also compared using the same outcome measures.Postoperatively, the BCVA was better in 44 eyes (84.6%); 12 eyes (23.1%) achieved a BCVA of 20/40 or better. Postoperative complications consisted of a transient intraocular pressure increase in 29 eyes (55.8%), hyphema in 10 (19.2%), neovascular glaucoma in 8 (15.4%), anterior chamber fibrin exudation in 7 (13.5%), vitreous hemorrhage in 7 (13.5%), retinal detachment in 3 (5.8%), and posterior capsule opacification in 1 (1.9%). In the diabetic patients, postoperative visual outcomes between the combined-surgery group and the sequential-surgery group were not significantly different; however, neovascular glaucoma occurred only in the combined-surgery group. Other complications were not different between the combined-surgery group and the sequential-surgery group. In the nondiabetic patients, the postoperative visual outcomes and complications between the 2 groups were not significantly different.Combined phacoemulsification, PPV, and IOL implantation was safe and effective in selected patients, with the clinical outcomes comparable to those of sequential surgery.
机译:为了评估超声乳化联合玻璃体切除术(PPV)和人工晶状体(IOL)植入在糖尿病和非糖尿病患者中的有效性和安全性,并将临床结果与序贯手术进行比较。首尔大学医学院,南首尔韩国。回顾性分析了52例(52眼)超声乳化,PPV和IOL联合植入的结果。主要结局指标为术前和术后最佳矫正视力(BCVA),术后BCVA为20/40或更高,以及术中和术后并发症。还比较了采用相同结局指标的联合手术和序贯手术。术后,BCVA改善44眼(84.6%)。 12眼(23.1%)的BCVA达到20/40或更高。术后并发症包括短暂性眼内压升高29眼(55.8%),眼睑积液10眼(19.2%),新生血管性青光眼8眼(15.4%),前房纤维蛋白渗出7眼(13.5%),玻璃体出血7眼( 13.5%),3例(5.8%)的视网膜脱离和1例(1.9%)的后囊混浊。在糖尿病患者中,联合手术组和序贯手术组的术后视觉结果无显着差异。但是,新生血管性青光眼仅在联合手术组中发生。联合手术组和序贯手术组之间的其他并发症没有差异。在非糖尿病患者中,两组之间的术后视觉结果和并发症无显着差异。联合超声乳化,PPV和IOL植入术对部分患者是安全有效的,其临床结果可与顺序手术相媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号